{"id":"W4417256274","doi":"10.1182/bloodadvances.2025018527","title":"Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"Pharmacyclics; Genentech; Incyte; Ipsen; BeiGene; Regeneron Pharmaceuticals; Seagen; Gilead Sciences; Loxo Oncology; TG Therapeutics; Pfizer; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Rituximab; Mantle cell lymphoma; Retrospective cohort study; Lymphoma; Maintenance therapy; Clinical trial; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008188811,0.0002404064,0.0005931411,0.0001744603,0.0002144501,0.0004659343,0.0003479538,0.0003995657,0.0006464935],"category_scores_gemma":[0.002128596,0.0001115047,0.0005315365,0.0002831149,0.0001948369,0.0003801419,0.0001958029,0.0006623539,0.00008435919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009575328,"about_ca_system_score_gemma":0.0007265717,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003191641,"about_ca_topic_score_gemma":0.008380339,"domain_scores_codex":[0.9997148,0.00009873197,0.00002388279,0.00005383981,0.00005160942,0.00005715912],"domain_scores_gemma":[0.9991546,0.0002512305,0.0002793145,0.0000523691,0.0000520999,0.0002105226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1557977,0.001892634,0.6244624,0.000478306,0.002526213,0.0005325729,0.0002108127,0.002371204,0.01327511,0.0001528407,0.003109645,0.1951905],"study_design_scores_gemma":[0.007555456,0.02979233,0.9534342,0.00008393308,0.001688861,0.001089892,0.0001016983,0.001982625,0.001874037,0.0001770579,0.002188343,0.00003144745],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996356,0.002989631,0.0000532933,0.0001588094,0.00001517734,0.00001244328,0.0001000128,0.000008003894,0.0003065514],"genre_scores_gemma":[0.9991954,0.0002548388,0.0000775856,0.0001168808,0.00003221397,0.000007452968,0.0002514592,0.000001317234,0.00006298925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003191641,"threshold_uncertainty_score":0.006947398,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002415960380034163,"score_gpt":0.2047243923878011,"score_spread":0.2023084320077669,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}